Christophe Guichard

Chief Financial Officer and Board Observer @ NETRIS Pharma

Country

Switzerland

City

Geneva

Industry

Biotechnology

Skill

Venture Capital, Private Equity, Start-ups, Corporate Finance, Entrepreneurship, Financial Analysis, Biotechnology, Valuation, Fundraising, Mergers & Acquisitions, Due Diligence, Start-up

Experience

Chief Financial Officer and Board Observer

NETRIS Pharma

2013-3 - Present · 13 yrs 7 mos

Geneva Area, Switzerland

Netris Pharma is a clinical stage - phase 2 biotechnology company pioneering an innovative approach in oncology targeting Netrin-1 to alleviate resistance to immunotherapy and chemotherapy

Founding General Partner & CFO

Eclosion Ventures

2008-3 - Present · 18 yrs 7 mos

Geneva Area, Switzerland

Switzerland’s premier seed and development fund dedicated to life-sciences. Based on a unique model, operating in partnership with a life science incubator, leading academic institutions, industrial companies and institutional investors, E. Ventures has developed and invested in some of Europe’s most promising biotech approaches. Director (2008-2015) and Managing Director of the life science incubator (2016-march 2017).

Member of the Board of Directors - Chairman of the Audit Committee

GeNeuro SA

2016-1 - 2023-6 · 7 yrs 6 mos

Geneva Area, Switzerland

Geneuro is a Euronext listed company that develops a complete novel approach against pathologies associated with Human Endogenous Retroviruses. The company is focusing on autoimmune diseases with a first indication in Multiple Sclerosis and targeting other neurological diseases, including ALS. Chief Financial Officer from 2008 to 2015. Member of the Board of Directors, Chaiman of the Audit Committee and Member of the Remuneration Committee since 2016.

Chief Financial Officer

Genkyotex S.A

2008-3 - 2012-3 · 4 yrs 1 mo

Geneva Area, Switzerland

GenKyoTex is the leader in the development of therapies targeting Nox Enzymes

VP Finance (1998-2005) and Chief Financial Officer (2006-2007)

Trader Classified Media

1998-11 - 2008-2 · 9 yrs 4 mos

Global Leader in the classified ads indutry. Managed under an exceptional entrepreneurial mindset, the Group implemented an intensive acquisition and build-up strategy in more than 20 countries, gradually transitioning to online activities. Successful dual listing (Nasdaq / AMF) in March 2000, senior financings (2000-2005) and major trade sales in 2006 (over $2bn).